The Asia Pacific gynecological device market will continue to expand through 2027 due to growing patient awareness of gynecologic treatments in this region. In particular, rising awareness of minimally invasive procedures in China and India, where these techniques have been underpenetrated, will result in increased adoption of associated devices.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for Gynecological Devices in Asia Pacific region across a 10-year period.
- Gynecological Devices - Market Insights - Asia Pacific (Supplemental)
Author(s): P Prasad, MS; Sumit Jain, MS Pharm
Prasad Pallemsetty is a team lead within the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at Decision Resources Group, specializing in the fields of gastroenterology, bariatrics, diabetes, ENT and bronchoscopy, gynecology, and urology. In particular, he has extensive knowledge of endoscopic devices, laparoscopic devices, and minimally invasive procedures. Prasad has attended many international conferences, including ENDOCON 2016 in Mumbai and Diabetes India 2018 in Kolkata, where he gained insight into the latest trends in endoscopic gastroenterology and diabetes treatments, respectively. Prasad holds a Bachelor’s degree in Pharmacy and a Master’s degree in Pharmaceutics.
Follow Prasad on Twitter: @PPrasad_DRG
Sumit Jain is an analyst within the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at Decision Resources Group, focusing on diagnostic imaging capital equipment and healthcare IT markets. Sumit holds a Bachelor's degree in Pharmacy from the Rajiv Gandhi Technical University, Bhopal, and a Master's degree in Pharmacoinformatics from the National Institute of Pharmaceutical Education and Research, Mohali.